DiaMedica Therapeutics annual net profit margin
2018
DiaMedica Therapeutics's net profit margin was −1,146.80% for fiscal 2018.
View full DiaMedica Therapeutics company overview| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2018 | 2018-12-31 | −1,146.80% | — |
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q3 2018 | 2018-09-30 | −277.40% | — |
The latest reported quarter, Q3 2018, shows −277.40%.
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review DiaMedica Therapeutics source filings ↗